LEADER 02480nam0 2200517 i 450 001 VAN00115413 005 20240806100753.978 017 70$2N$a978-3-319-28095-0 100 $a20180308d2016 |0itac50 ba 101 $aeng 102 $aCH 105 $a|||| ||||| 200 1 $aSystem engineering approach to planning anticancer therapies$fAndrzej Swierniak ... [et al.] 210 $a[Cham]$cSpringer$d2016 215 $aIX, 235 p.$cill.$d24 cm 500 1$3VAN00243215$aSystem engineering approach to planning anticancer therapies$91523670 606 $a35Q92$xPDEs in connection with biology, chemistry and other natural sciences [MSC 2020]$3VANC031096$2MF 606 $a37N25$xDynamical systems in biology [MSC 2020]$3VANC020364$2MF 606 $a49N90$xApplications of optimal control and differential games [MSC 2020]$3VANC033550$2MF 606 $a92C42$xSystems biology, networks [MSC 2020]$3VANC029020$2MF 606 $a92C50$xMedical applications (general) [MSC 2020]$3VANC027825$2MF 606 $a92D25$xPopulation dynamics (general) [MSC 2020]$3VANC022805$2MF 606 $a93-10$xMathematical modeling or simulation for problems pertaining to systems and control theory [MSC 2020]$3VANC025288$2MF 606 $a93B35$xSensitivity (robustness) [MSC 2020]$3VANC022855$2MF 606 $a93Cxx$xModel systems in control theory [MSC 2020]$3VANC022769$2MF 610 $aAntibacterial drug resistance$9KW:K 610 $aAnticancer therapies$9KW:K 610 $aBiomathematical modelling$9KW:K 610 $aCell Cycle Analysis$9KW:K 610 $aCell cycle$9KW:K 610 $aDrug resistance$9KW:K 610 $aOptimimzation$9KW:K 610 $aPopulation dynamics$9KW:K 610 $aSignalling pathway dynamics$9KW:K 610 $aStructure models$9KW:K 620 $aCH$dCham$3VANL001889 702 1$aSwierniak$bAndrzej$3VANV089332 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240906$gRICA 856 4 $uhttp://dx.doi.org/10.1007/978-3-319-28095-0$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15 912 $fN 912 $aVAN00115413 950 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS SBA EBOOK 2537 $e15EB 2537 20180308 996 $aSystem engineering approach to planning anticancer therapies$91523670 997 $aUNICAMPANIA